Literature DB >> 5775034

Effects of mithramycin on Paget's disease of bone.

W G Ryan, T B Schwartz, C P Perlia.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5775034     DOI: 10.7326/0003-4819-70-3-549

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  18 in total

1.  Medical staff conference. Paget disease of bone.

Authors: 
Journal:  West J Med       Date:  1978-09

2.  Treatment of Paget's disease of bone with once a week injections of salmon calcitonin.

Authors:  A Avramides; A Flores; J Derose; S Wallach
Journal:  Br Med J       Date:  1975-09-13

Review 3.  The contribution of Sir James Paget (1814-1894) to the study of rheumatic disease.

Authors:  W Buchanan
Journal:  Clin Rheumatol       Date:  1996-09       Impact factor: 2.980

4.  Inhibition of parathyroid hormone stimulated bone resorption in vitro by the antibiotic mithramycin.

Authors:  C Minkin
Journal:  Calcif Tissue Res       Date:  1973-12-31

5.  Clinical and biochemical studies of Paget's disease of bone with emphasis on the effects of RNA inhibitors actinomycin D and mithrawycin.

Authors:  J J Fennelly
Journal:  Ir J Med Sci       Date:  1971-10       Impact factor: 1.568

Review 6.  Drugs for disorders of bone: pharmacological and clinical considerations.

Authors:  G R Mundy; L G Raisz
Journal:  Drugs       Date:  1974       Impact factor: 9.546

Review 7.  Recent progress in calcium metabolism: clinical application.

Authors:  G S Gordan
Journal:  Calif Med       Date:  1971-05

Review 8.  Recent advances in the unerstanding and management of metabolic bone disease.

Authors:  R Smith
Journal:  Proc R Soc Med       Date:  1970-09

9.  Pseudouridine excretion--a reflection of high RNA turnover in Paget's disease.

Authors:  J J Fennelly; A Hogan
Journal:  Ir J Med Sci       Date:  1972 Jul-Sep       Impact factor: 1.568

10.  Thyroxine-induced stimulation of hepatic cell transport of calcium and magnesium.

Authors:  S Wallach; J V Bellavia; P J Gamponia; P Bristrim
Journal:  J Clin Invest       Date:  1972-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.